Glossary · EU medical devices: MDR
Clinical benefit (MDR)
Also known as: Clinical benefit of a medical device
German: Klinischer Nutzen
Under the EU Medical Device Regulation (EU) 2017/745, clinical benefit means the positive impact of a device on the health of an individual, expressed in terms of a meaningful, measurable, patient-relevant clinical outcome, including outcomes related to diagnosis, or a positive impact on patient management or public health.
- EU
- MDR
- Technical documentation
In one sentence
Clinical benefit (MDR Art. 2(53)): a meaningful, measurable, patient-relevant positive outcome of a device, incl. diagnosis or patient management.
Example
A wound dressing manufacturer states the clinical benefit as a shorter time to wound closure in diabetic foot ulcers, with the outcome measure and the data from the clinical evaluation; “improves comfort” alone is not stated as a clinical benefit.
Explained in context
This term is a station of a mini course
- The medical-device evidence chain: from intended purpose to post-market evidenceStation: Clinical and performance evidence · Claims as controlled informationStart the course
Context cards connect this term with others to answer one question. Also in British English and German.
- Claims are controlled information objects: from claim to evidence in a medical device fileHow should claims about a medical device be managed so that each one is backed by evidence?UKDeutsch
- The intended purpose as the semantic anchor of the technical fileWhy is the intended purpose the reference point of every document in a medical-device technical file?UKDeutsch
- Clinical evidence owner: a functional roleWho keeps the clinical and performance evidence of a device in step with the IFU, the claims and the post-market data?UKDeutsch
- The medical-device evidence chain: from intended purpose to post-market evidenceHow do the parts of a medical device’s technical documentation connect — and what has to be in place before an AI function may answer from it?UKDeutsch
How it applies
- Stated, measured, supported: The clinical evaluation plan names the intended clinical benefits with relevant and specified outcome parameters (Annex XIV Part A). The clinical evaluation has to show them with sufficient clinical evidence.
- Feeds the benefit-risk: The clinical benefits are one side of the benefit-risk determination.
- Public statement: For implantable and class III devices, the SSCP summarizes the clinical benefits for users and, where relevant, patients.
- Technical documentation: Keep each clinical benefit as a controlled statement with its outcome parameter and the evidence that supports it, and check every claim in the IFU, the label and the marketing material against it; see claims matrix.
Clinical benefit vs. clinical performance
Clinical performance (Art. 2(52)) is the ability of a device to achieve its intended purpose as claimed, leading to a clinical benefit. A device can perform as designed — measure accurately, deliver the dose — without the clinical benefit being shown; the MDR asks for both.
External references
- Regulation (EU) 2017/745 (MDR) — Article 2(52) and (53), Annex XIV